Ghent - February 12, 2008 – 8.00 AM (CET) – Last year, Innogenetics decided to focus on the development and sales of diagnostic products, and GENimmune N.V. was incorporated as a fully owned ...

BRUSSELS (Reuters) - Belgian drugmaker Solvay SA launched a takeover offer for Innogenetics NV on Friday, valuing the maker of disease diagnostic products at 177.6 million euros ($277 million). Sign ...

BRUSSELS, July 9 (Reuters) - Belgian drugmaker Solvay increased its bid for biotech company Innogenetics on Wednesday, beating off a rival offer from U.S. disease diagnosis firm Gen-Probe Inc . Sign ...

Solvay Pharmaceuticals S.A., a subsidiary of Solvay, the chemical and pharmaceutical group, and Innogenetics N.V., the biotechnological company, today jointly announced that Solvay Pharmaceuticals S.A ...

Solvay Pharmaceuticals has tabled a bid of 177.6 million euros to acquire fellow Belgian firm Innogenetics in a bid to expand its personalised medicines operations. Solvay Pharmaceuticals has tabled a ...

The USA’s Gen-Probe has launched an offer for Innogenetics which tops an earlier bid made by fellow Belgian firm Solvay. The USA’s Gen-Probe has launched an offer for Innogenetics which tops an ...

Cash tender offer will expand Gen-Probe’s molecular diagnostic market reach into Europe. Gen-Probe is proposing to acquire Innogenetics for €215 million, or $332.19 million, in cash. The conditional ...

Third Wave Technologies Inc. and Innogenetics have jointly announced that the companies have reached an agreement by which Third Wave Technologies will receive a non-exclusive license to sell ...

LONDON (MarketWatch) -- Biopharmaceutical Innogenetics said Thursday that the U.S. District Court for the Western District of Wisconsin has entered a permanent injunction against Abbott Laboratories .

U.S. Court of Appeals denied Abbott’s motion for stay of injunction regarding infringement of HCV genotyping technology. The U.S. Court of Appeals denied Abbott Laboratories’ motion for a stay of ...